Back
Galectin Therapeutics Stock Price Chart
What's Nvidia doing next??
Click here now to learn more about Nvidia's next AI move.
Sell
34
GALT
Galectin Therapeutics
Last Price:
2.17
Seasonality Move:
-1.15%
7 Day Trial
ALL ACCESS PASS
$
7
A massive $1 Trillion AI superproject is underway
Click here to discover these key companies behind this $1 trillion Superproject- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GALT is experiencing selling pressure, which indicates risk of future bearish movement.
Galectin Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.23 | Sell |
| 20-day SMA: | 2.44 | Sell |
| 50-day SMA: | 2.87 | Sell |
| 200-day SMA: | 2.27 | Sell |
| 8-day EMA: | 2.27 | Sell |
| 20-day EMA: | 2.43 | Sell |
| 50-day EMA: | 2.65 | Sell |
| 200-day EMA: | 2.37 | Sell |
Galectin Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.18 | Sell |
| Relative Strength Index (14 RSI): | 34.23 | Sell |
| Chaikin Money Flow: | -161511 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.28 - 2.72) | Sell |
| Bollinger Bands (100): | (2.02 - 3.3) | Sell |
Galectin Therapeutics Technical Analysis
| Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Galectin Therapeutics Stock
Is Galectin Therapeutics Stock a Buy?
- Galectin Therapeutics share price is 2.15 while GALT 8-day simple moving average is 2.23, which is a Sell signal.
- The stock price of GALT is 2.15 while Galectin Therapeutics 20-day SMA is 2.44, which makes it a Sell.
- Galectin Therapeutics 50-day simple moving average is 2.87 while GALT share price is 2.15, making it a Sell technically.
- GALT stock price is 2.15 and Galectin Therapeutics 200-day simple moving average is 2.27, creating a Sell signal.
GALT Technical Analysis vs Fundamental Analysis
Sell
34
Galectin Therapeutics (GALT)
is a Sell
Is Galectin Therapeutics a Buy or a Sell?
-
Galectin Therapeutics stock is rated a Sell
The current Galectin Therapeutics [GALT] share price is $2.15. The Score for GALT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Galectin Therapeutics Stock Info
Market Cap:
133.62M
Price in USD:
2.15
Share Volume:
161.51K
Galectin Therapeutics 52-Week Range
52-Week High:
4.27
52-Week Low:
1.35
Sell
34
Galectin Therapeutics (GALT)
is a Sell
Galectin Therapeutics Share Price Forecast
-
What is the Galectin Therapeutics stock price today?
The Galectin Therapeutics stock price is 2.15 USD today. -
Will GALT stock go up or go down?
Galectin Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Galectin Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Galectin Therapeutics is overvalued.
Is Galectin Therapeutics Stock a Buy?
- Galectin Therapeutics share price is 2.15 while GALT 8-day exponential moving average is 2.27, which is a Sell signal.
- The stock price of GALT is 2.15 while Galectin Therapeutics 20-day EMA is 2.43, which makes it a Sell.
- Galectin Therapeutics 50-day exponential moving average is 2.65 while GALT share price is 2.15, making it a Sell technically.
- GALT stock price is 2.15 and Galectin Therapeutics 200-day simple moving average is 2.37, creating a Sell signal.
Technical Analysis of Galectin Therapeutics
Should I short Galectin Therapeutics stock?
- GALT Moving Average Covergence Divergence (MACD) indicator is -0.18, suggesting Galectin Therapeutics is a Sell
- Galectin Therapeutics Relative Strength Index (RSI) is 34.23, which suggest Galectin Therapeutics is oversold
- The Bollinger Bands (25) for Galectin Therapeutics is (2.28 - 2.72), which suggest Galectin Therapeutics is a Sell
- The Bollinger Bands (100) for Galectin Therapeutics is (2.02 - 3.3), which suggest Galectin Therapeutics is a Sell
* Galectin Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.